Other
Despite hype, private payers slow to adopt oncology value-based models
Abstract
Oncology Institute’s Dawn Holcombe, MBA, FACMPE, ACHE, shares her views on the OCM program, what CAR T-cell therapy means for the future of reimbursement, and some epic...
Paper Details
Title
Despite hype, private payers slow to adopt oncology value-based models
Published Date
Jan 19, 2018
Journal